Megan Catlin is a results-driven drug policy researcher with specialization in demography and data science applications to public health, national security, and public policy. As a Senior Data Scientist at the White House Office of National Drug Control Policy, she serves as an expert in a diverse portfolio of technical topics spanning drug availability and use while cultivating a passion for innovating analytical solutions to barriers to 21st century data insights. Megan is recognized for her persistently solution-oriented approach to coordinating and creating the missing relationships, methods, and tools that decisionmakers need to make smarter, timelier, and more efficient choices. One such project she spearheaded is the ONDCP Drug Overdose Surveillance Dashboard; a first-of-its-kind tool for tracking overdose, naloxone administrations, and related metrics nationwide, at state and county levels, by suspected drug involvement, and along leading demographic dimensions. She’s written White Papers on topics such as, tracking community vulnerability to the overdose epidemic, using time series analysis to identify growing disparities in opioid-involved mortality rates by race, creating an integrated system of drug data and statistics, and the economic benefit and ROI of substance use disorder treatment services. She’s presented at MIT and medical examiner and EMS conferences and consulted on data science projects with entities like West Point’s Science Network Center, a Director of the Merida Initiative, and the Council for State and Territorial Epidemiologists. Her work been published in The Journal of the American Medical Association, The Journal of Substance Abuse Treatment, and The Journal of Analytical Toxicology.